Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2022-04-19 | Dr. Egbuonu-Davis brings to the Board broad strategic and operational experience in pharmaceuticals, public health and consulting. ... Dr. Egbuonu-Davis was appointed to the Board effective July 30, 2021. ... Effective immediately following the Annual Meeting, the Board of Directors has appointed Dr. Egbuonu-Davis to the Nominating and Corporate Governance Committee. ... The table below sets forth the compensation paid to our non-employee directors for 2021: Lisa C. Egbuonu-Davis Fees earned or paid in cash $31,253, Stock Awards $126,572, Total $157,825. |
| 2023-04-21 | Dr. Lisa C. Egbuonu-Davis, Age 65, Independent Director since 2021. Serves on Nominating and Corporate Governance Committee. 2022 Director Compensation: Fees earned or paid in cash $82,521, Stock awards $149,979, Total $232,500. |
| 2024-04-23 | Dr. Egbuonu-Davis served as Vice President, Medical Innovations for DH Diagnostics, LLC... She joined the Board of Avanos Medical, Inc. in March 2023 and Phreesia, Inc. in 2023... 2023 Non-Employee Director Compensation: Fees earned or paid in cash $82,500, Stock Awards $150,000, Total $232,500. |
Data sourced from SEC filings. Last updated: 2026-02-03